Navigation Links
Senator Blumenthal, a Strong Advocate for Women's Health, Visits Hologic's Manufacturing Facility in Danbury, CT
Date:8/21/2012

BEDFORD, Mass., Aug. 21, 2012 /PRNewswire/ --  Hologic, Inc. (NASDAQ: HOLX) announced that today it hosted Senator Richard Blumenthal (D-Conn.) and Rep. Chris Murphy (D-CT 5) at the Company's women's imaging manufacturing facility in Danbury, CT. The Senator and Representative participated in a discussion with local breast cancer leaders, saw a demonstration of Hologic's newest technology, Dimensions 3D mammography (breast tomosynthesis) and toured the Company's manufacturing plant.

As a vocal proponent of breast cancer screening and annual mammography exams, Senator Blumenthal emphasized the important role Hologic plays in developing cutting-edge healthcare solutions for women and also in powering the local economy.

Connecticut has been a leader in promoting women's breast health. The state in 2009 became the first to enact a law requiring doctors to provide women with a breast density score after their mammograms. Dense breast tissue can make it more difficult to interpret a 2D mammogram, as breast cancer has the ability to hide behind the dense tissue.

Dr. Liane Philpotts, chief of Breast Imaging at the Yale University School of Medicine, was among those at Hologic's manufacturing facility in Danbury who discussed her experience with the Company's advanced Dimensions 3D breast tomosynthesis system. Smilow Cancer Hospital at Yale-New Haven was the first facility in Connecticut to offer Hologic's new screening and diagnosis tool.

"With Hologic's 3D technology, we can see the entire breast more clearly in one millimeter slices," said Dr. Philpotts. "This allows us to find additional cancers earlier and also dismiss ambiguous spots that are actually normal breast tissue."

Dr. Philpotts led a Yale-New Haven Hospital study that showed adding 3D to a screening mammography exam reduced recall rates by 40 percent. With conventional 2D mammography systems, overlapping breast tissue can hide small cancers or alternately can cause normal areas to look suspicious.[1] Hologic's Dimensions 3D mammography allows radiologists to identify and characterize individual breast structures without the confusion of overlapping tissue and gives the doctors the increased ability to detect cancer and rule out non-cancerous tissue without additional imaging.

"We are honored to host Senator Blumenthal at Hologic and to show him the cutting-edge advancements we are developing to help women live longer, stronger, healthier lives," said Rob Cascella, President and Chief Executive Officer of Hologic. "We believe 3D mammography is the most important advancement for mammography to date for the early detection of breast cancer and we look forward to ensuring women across the state and the world have access to our groundbreaking technology."

Hologic's Dimensions 3D system was approved by the U.S. Food and Drug Administration in February 2011 and is available to millions of women throughout the United States. In addition to the more than 300 sites that have a 3D system in the U.S., the technology is installed in hospitals and imaging centers in 26 countries on six continents.  The product was approved for sale in Europe and other countries recognizing the CE mark in 2009.

About Hologic:Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on breast health, diagnostics, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.

Hologic and Dimensions and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Forward-Looking Statement Disclaimer:This News Release may contain forward-looking information that involves risks and uncertainties, including statements about the use of the Dimensions system. There can be no assurance the tests or systems will achieve the benefits described herein and that such benefits will be replicated in any particular manner as the actual effect of the use of the tests and systems can only be determined on a case-by-case basis depending on the particular circumstances and installation in question. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic filings with the Securities and Exchange Commission.

[1] Philpotts, L.; Raghu, M.; Durand, M.; Hooley, R.; Vashi, R.; Horvath, L.; Geisel, J.; Butler, R. Yale University School of Medicine. Initial Experience With Digital Breast Tomosynthesis in Screening Mammography. Presented May 3, 2012 at American Roentgen Ray Society Annual Meeting.

Hologic Media Contacts: Olga Karagiannis

Jim Culley, PhDSr. Specialist, Global Publicity & Advertising

Corporate Marketing, Senior DirectorHologic, Inc.

Hologic, Inc.Olga.Karagiannis@Hologic.com

Jim.Culley@Hologic.comTel: +1 781 761 7069

Tel: +1 781 999 7583 


'/>"/>
SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nouveau Life Pharmaceuticals (NOUV) Releases Calcium & Vitamin D for Strong Bones
2. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
3. Frost & Sullivan: Improving Economies in Indonesia and Vietnam Present Strong Growth Potential in Healthcare
4. Biosensors Reports Strong Sales and Profitability in the First Quarter of Fiscal Year 2013
5. Strong Endorsements cited for MedQIA - Imaging CROs Novel Bone Scan Scoring System at the ASCO 2012 Annual Meeting
6. Need for Reduced Healthcare Outlays Creates Strong Growth Potential for Medical Imaging Services, Says Frost & Sullivan
7. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
8. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
9. Strong Booking Levels For Informex 2013
10. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
11. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):